Paraneoplastische erosive Arthritis, Rheumafaktor- und Anti-CCP-positiv, bei B-Zell-Lymphom

M. Braun; I. Matveev; I. Hartig

doi:10.1055/s-0037-1618429

Arthritis und Rheuma, Table of Contents

Arthritis und Rheuma 2017; 37(04): 247-249
DOI: 10.1055/s-0037-1618429

Der besondere Fall

Schattauer GmbH

Paraneoplastische erosive Arthritis, Rheumafaktor- und Anti-CCP-positiv, bei B-Zell-Lymphom

Authors

M. Braun

¹HELIOS Seehospital Sahlenburg, Abt. Innere Medizin/Rheumatologie, Cuxhaven
I. Matveev

¹HELIOS Seehospital Sahlenburg, Abt. Innere Medizin/Rheumatologie, Cuxhaven
I. Hartig

¹HELIOS Seehospital Sahlenburg, Abt. Innere Medizin/Rheumatologie, Cuxhaven

Abstract

Full Text

References

Literatur
1 Naschitz JE, Rosner I. Musculoskeletal syndromes associated with malignancy (excluding hypertrophic osteoarthropathy). Curr Opin Rheumatol 2008; 20: 100-105.
2 Jardin F. Development of autoimmunity in lymphoma. Expert Rev Clin Immunol 2008; 4 (02) 247-266.
3 Van der Cruyssen B, Hoffman IE, Zmierczak H. et al. Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis. Ann Rheum Dis 2005; 64: 1145-1149.
4 Mohammed K, Pope J, Le Riche N. et al. Association of severe inflammatory polyarthritis in primary Sjögren‘s syndrome: clinical, serologic, and HLA analysis. J Rheumatol 2009; 36: 1937-1342.
5 Kakumanu P, Sobel ES, Narain S. et al. Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis. J Rheumatol 2009; 36: 2682-2690.
6 Elkayam O, Segal R, Lidgi M. et al. Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis. Ann Rheum Dis 2006; 65: 1110-1112.
7 Kakumanu P, Yamagata H, Sobel ES. et al. Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide. Arthritis Rheum 2008; 1576-1581.
8 Shafaghi A, Mansour-Ghanaei F, Rostamnejad M. et al. Anti-cyclic citrullinated peptide antibodies in ulcerative colitis, and its relation with disease activity. Med J Islam Repub Iran 2014; 28: 76 [eCollection]
9 Jardin F. Development of autoimmunity in lymphoma. Expert Rev Clin Immunol Mar 2008; 4 (02) 247-266.
10 Morel J, Deschamps V, Toussirot E. et al. Characteristics and survival of 26 patients with paraneoplastic arthritis. Ann Rheum Dis 2008; 67: 244-247.
11 Naschitz JE, Rosner I. Musculoskeletal syndromes associated with malignancy (excluding hypertrophic osteoarthropathy). Curr Opin Rheumatol 2008; 20: 100-105.
12 Marinez-Levin M, Pineda C. Hypertrophic osteoarthropathy. In: Hochberg MC. et al. eds. Rheumatology, 3^rd ed. Edinburgh: Mosby; 2003: 1763-1767.
13 Dickinson CJ. The aetiology of clubbing and hypertrophic osteoarthropathy. Eur J Clin Invest 1993; 23: 330-338.
14 Hartig I, Matveeva I, Braun MG. Bei neu aufgetretenen Trommelschlegelfingern daran denken: Marie-Bamberger-Syndrom. Z Rheumatol 2015; 74 (08) 728-730.
15 Abe Y, Kurita S, Ohkubo Y. et al. A case of pulmonary adenocarcinoma associated with hypertrophic osteoarthropathy due to vascular endothelial growth factor. Anticancer Res 2002; 22: 3485-3488.
16 Olan F, Portela M, Navarro C. et al. Circulating vascular endothelial growth factor concentrations in a case of pulmonary hypertrophic osteoarthropathy. Correlation with disease activity. J Rheumatol 2004; 31: 614-616.
17 Mariette X, de Roquancourt A, d‘Agay MF. et al. Monarthritis revealing non-Hodgkin‘s T cell lymphoma of the synovium. Arthritis Rheum 1988; 31 (04) 571.
18 Ehrenfeld M, Gur H, Shoenfeld Y. Rheumatologic features of hematologic disease. Curr Opin Rheumatol 1999; 11: 62-67.
19 Caldwell DS. Musculoskeletal syndromes associated with malignancy. In: Kelley WN, Harris ED, Ruddy S, Sledge CB. Hrsg. Textbook of Rheumatology. Philadelphia: WB Saunders; 1997: 1521-1525.
20 Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol 1995; 164: 129-134.
21 Ehrenfeld M, Gur H, Shoenfeld Y. Rheumatologic features of hematologic disease. Curr Opin Rheumatol 1999; 11: 62-67.